Zimbabwe has turned down a significant American healthcare agreement valued at $367m (272 million pounds) over five years over Washington's insistence on sensitive data.
This move was revealed after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official representative has since clarified that the US was demanding access to health data for scientific study and commercial gain but was not willing to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more negotiations to secure a deal suitable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Context
This development follows a similar situation in Kenya, where a high court halted a related deal with the US after concerns were raised about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral agreements to boost transparency and accountability.
According to statements, Sixteen African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, with no equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"In essence, our country would provide the raw materials for scientific discovery without any certainty that the end products would be available to our people should a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining frameworks previously set up through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing system designed to deal with potential pandemics.
"This framework is designed to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome continued discussions with our US partners on how future co-operation could be structured in a manner that respects the sovereignty and dignity of each country."
Medical Community Response
A leading public health body said it recognised the government's concerns, but urged that talks need to persist given that a large portion of the country's Aids initiatives depended on international support.
"In cases where technical issues arise, including those involving information security or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," the group said.
This impasse emphasises the ongoing debate between receiving vital international aid and protecting local interests in an ever more interconnected world.